Estrella Immunopharma, Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Estrella Immunopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • Estrella Immunopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was -156 %, a 191% decline year-over-year.
  • Estrella Immunopharma, Inc. annual Return On Equity for 2024 was -91.7 %, a 164% decline from 2023.
  • Estrella Immunopharma, Inc. annual Return On Equity for 2023 was 143 %, a 347% increase from 2022.
  • Estrella Immunopharma, Inc. annual Return On Equity for 2022 was 31.9 %, a 41% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -156 -329 -191% Jul 1, 2024 Sep 30, 2024
Q2 2024 -91.7 -200 -184% Apr 1, 2024 Jun 30, 2024
Q1 2024 -86.6 -258 -151% Jan 1, 2024 Mar 31, 2024
Q4 2023 1.31K +1.12K +567% Oct 1, 2023 Dec 31, 2023
Q3 2023 172 +18.3 +11.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 109 +116 Apr 1, 2023 Jun 30, 2023
Q1 2023 171 +228 Jan 1, 2023 Mar 31, 2023
Q4 2022 197 +143 +264% Oct 1, 2022 Dec 31, 2022
Q3 2022 154 Jul 1, 2022 Sep 30, 2022
Q2 2022 -7.28 Apr 1, 2022 Jun 30, 2022
Q1 2022 -57.3 Jan 1, 2022 Mar 31, 2022
Q4 2021 54.1 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.